A detailed history of Journey Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Journey Advisory Group, LLC holds 50,978 shares of ABBV stock, worth $9.44 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
50,978
Previous 50,929 0.1%
Holding current value
$9.44 Million
Previous $7.89 Million 17.63%
% of portfolio
1.15%
Previous 1.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $7,831 - $8,922
49 Added 0.1%
50,978 $9.28 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $284,006 - $319,858
-2,064 Reduced 3.89%
50,929 $7.89 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $276,664 - $320,280
2,071 Added 4.07%
52,993 $7.9 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $1.51 Million - $1.88 Million
-11,387 Reduced 18.28%
50,922 $6.86 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $1.24 Million - $1.43 Million
8,579 Added 15.97%
62,309 $9.93 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $910,909 - $1.09 Million
6,586 Added 13.97%
53,730 $8.69 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $341,698 - $391,905
2,546 Added 5.71%
47,144 $6.33 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $2.69 Million - $3.42 Million
19,539 Added 77.97%
44,598 $6.25 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $500,864 - $621,431
3,795 Added 17.85%
25,059 $4.06 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $284,152 - $359,534
2,645 Added 14.21%
21,264 $2.88 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $182,263 - $206,896
1,713 Added 10.13%
18,619 $2.01 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $152,028 - $169,368
1,445 Added 9.35%
16,906 $1.9 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $54,832 - $60,364
536 Added 3.59%
15,461 $1.67 Million
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $1.2 Million - $1.62 Million
14,925 New
14,925 $1.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $327B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Journey Advisory Group, LLC Portfolio

Follow Journey Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Journey Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Journey Advisory Group, LLC with notifications on news.